Factors Associated with Persistent Sputum Positivity at the End of the Second Month of Tuberculosis Treatment in Lithuania

Background Non-conversion of sputum smear and culture prolongs the infectivity of the patient and has been associated with unfavorable outcomes. We aimed to evaluate factors associated with persistent sputum positivity at the end of two months of treatment of new case pulmonary tuberculosis (TB). Methods Data of 87 human immunodeficiency virus-negative patients with culture-positive drug-susceptible pulmonary TB admitted to local university hospital between September 2015 and September 2016 were reviewed. Factors associated with sputum smear and/or culture positivity at the end of the second month of treatment were analyzed. Results Twenty-two patients (25.3%) remained smear and/or culture-positive. Male sex, lower body mass index (BMI), unemployment, alcohol abuse, higher number of lobes involved and cavities on chest X-rays, shorter time to detection (TTD) on liquid cultures, higher respiratory sample smear grading and colony count in solid cultures, higher C-reactive protein, erythrocyte sedimentation rate, leukocytosis, thrombocytosis, and anemia were all significantly associated with persistent sputum positivity. However, in the logistic regression analysis only male sex, lower BMI, alcohol abuse, higher radiological involvement, cavitation, higher smear grading, higher colony count in solid cultures and shorter TTD were determined as independent factors associated with persistent sputum positivity at the end of 2 months of treatment. Conclusion In conclusion, higher sputum smear and culture grading at diagnosis, shorter TTD, higher number of lobes involved, cavitation, male sex, alcohol abuse, and lower BMI were independently associated with persistent sputum positivity. These factors should be sought when distinguishing which patients will remain infectious longer and possibly have worse outcomes.

• Publication year

  2018

• Venue

  Tuberculosis and Respiratory Diseases

• Publication date

  2018-06-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.4046/trd.2017.0096PMID 29926543PMCID 6030656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Delay in sputum smear conversion and outcomes of smear-positive tuberculosis patients: a retrospective cohort study in Bafoussam, Cameroon

  2015cited by this paper
• Outcome correlation of smear-positivity but culture-negativity during standard anti-tuberculosis treatment in Taiwan

  2015cited by this paper
• European Centre for Disease Prevention and Control.

  2014cited by this paper
• Anemia at the Initiation of Tuberculosis Therapy Is Associated with Delayed Sputum Conversion among Pulmonary Tuberculosis Patients in Dar-es-Salaam, Tanzania

  2014cited by this paper
• Factors influencing sputum conversion among smear-positive pulmonary tuberculosis patients in Morocco

  2013cited by this paper
• Baseline Predictors of Sputum Culture Conversion in Pulmonary Tuberculosis: Importance of Cavities, Smoking, Time to Detection and W-Beijing Genotype

  2012cited by this paper
• Tuberculosis surveillance and monitoring in Europe 2012.

  2012cited by this paper
• Accuracy of self-reported drinking: observational verification of 'last occasion' drink estimates of young adults.

  2011cited by this paper
• A systematic review of risk factors for death in adults during and after tuberculosis treatment.

  2011cited by this paper
• WHO Global Status Report on Alcohol and Health 2011

  2011cited by this paper
• Predictors and mortality associated with treatment default in pulmonary tuberculosis.

  2010cited by this paper
• Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis

  2010cited by this paper
• Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients.

  2010cited by this paper
• Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

  2009cited by this paper
• Factors influencing time to smear conversion in patients with smear‐positive pulmonary tuberculosis

  2009cited by this paper
• Time to detection of Mycobacterium tuberculosis in BACTEC systems as a viable alternative to colony counting.

  2008cited by this paper
• Factors influencing sputum smear conversion at one and two months of tuberculosis treatment.

  2008cited by this paper
• Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions.

  2007cited by this paper
• Moderate alcohol consumption and the immune system: A review

  2007cited by this paper
• Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis

  2006cited by this paper
• Factors predicting persistent sputum smear positivity among pulmonary tuberculosis patients 2 months after treatment.

  2003cited by this paper
• Factors associated with time to sputum smear conversion in active pulmonary tuberculosis.

  2003cited by this paper
• Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis.

  1998cited by this paper
• Incidence and significance of acid-fast bacilli in sputum smears at the end of antituberculous treatment.

  1996cited by this paper
• [International Union against Tuberculosis and Lung Disease].

  1989cited by this paper
• Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment.

  1980cited by this paper
• Short-course (6-month) cooperative tuberculosis study in Poland: results 30 months after completion of treatment.

  1980cited by this paper

• Time to recovery among tuberculosis patients receiving anti-Koch’s drug in Ibadan, Oyo State, Nigeria

  2025cites this paper
• Sociodemographic and Clinical Factors Associated with Tuberculosis Mortality in Hamadan Province, Iran

  2025cites this paper
• Treatment outcomes in cavitary multidrug-resistant/rifampicin-resistant tuberculosis and risk factors for cavity closure: a retrospective cohort study in Southwest China

  2025cites this paper
• Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled Trial

  2024influential citation
• Identification of Factors Determining Patterns of Serum C-Reactive Protein Level Reduction in Response to Treatment Initiation in Patients with Drug-Susceptible Pulmonary Tuberculosis

  2024cites this paper
• A time-to-event modelling of sputum conversion within two months after antituberculosis initiation among drug-susceptible smear positive pulmonary tuberculosis patients: Implementation of internal and external validation.

  2024cites this paper
• Prevalence and factors associated with sputum smear non-conversion after two months of tuberculosis treatment among smear-positive pulmonary tuberculosis patients in Rwanda: a cross-sectional study

  2023cites this paper
• Treatment outcomes of extended versus nonextended intensive phase in pulmonary tuberculosis smear positive patients with delayed sputum smear conversion: A retrospective cohort study at primary care clinics in Kota Kinabalu.

  2023cites this paper
• The Cavity as a Lasting Abode for Tuberculous Bacilli

  2022cites this paper
• Factors influencing delay in sputum conversion in smear-positive pulmonary tuberculosis patients in primary care in Kuala Lipis Pahang

  2022cites this paper
• Systematic assessment of clinical and bacteriological markers for tuberculosis reveals discordance and inaccuracy of symptom-based diagnosis for treatment response monitoring

  2022cites this paper
• Smear grading at initial treatment association with treatment outcomes among new smear positive pulmonary tuberculosis patients: A retrospective study.

  2022cites this paper
• Higher Serum Cholesterol Levels Are Associated With Reduced Systemic Inflammation and Mortality During Tuberculosis Treatment Independent of Body Mass Index

  2021cites this paper
• Prediction of the duration needed to achieve culture negativity in patients with active pulmonary tuberculosis using convolutional neural networks and chest radiography.

  2021cites this paper
• Sputum smear grading and associated factors among bacteriologically confirmed pulmonary drug-resistant tuberculosis patients in Ethiopia

  2021cites this paper
• Determining the risk factors associated with delayed sputum conversion at the end of the intensive phase among tuberculosis patients.

  2021cites this paper
• Cavities Herald Persistent Sputum Positivity

  2021cites this paper
• Predictors of smear non-conversion among new-treatment pulmonary tuberculosis: a single center case-control study in Indonesia

  2020cites this paper
• Is International Travel an Emerging Issue on Transmission of Beijing Lineage Mycobacterium tuberculosis?

  2020cites this paper
• A valuable computed tomography-based new diagnostic tool for severe chest lesions in active pulmonary tuberculosis: combined application of influencing factors

  2020cites this paper
• Sputum Conversion as a Predictor to Treatment Outcome in Tuberculosis Control in Kenya

  2020cites this paper
• Drug-Resistant Tuberculosis: Correlation between Positivity of Acid-Fast Bacilli Sputum and Time to Conversion on Patients with Short-Term Treatment Regimen

  2020cites this paper
• Tuberculosis infectious pool and associated factors in East Gojjam Zone, Northwest Ethiopia

  2019cites this paper